DK1480953T3 - Fremgangsmåde til fremstilling af aripiprazol - Google Patents

Fremgangsmåde til fremstilling af aripiprazol

Info

Publication number
DK1480953T3
DK1480953T3 DK03780889T DK03780889T DK1480953T3 DK 1480953 T3 DK1480953 T3 DK 1480953T3 DK 03780889 T DK03780889 T DK 03780889T DK 03780889 T DK03780889 T DK 03780889T DK 1480953 T3 DK1480953 T3 DK 1480953T3
Authority
DK
Denmark
Prior art keywords
aripiprazole
preparation
Prior art date
Application number
DK03780889T
Other languages
English (en)
Other versions
DK1480953T4 (da
Inventor
Hisayuki Tsujimori
Tatsuya Yamaguchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32652780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1480953(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1480953T3 publication Critical patent/DK1480953T3/da
Publication of DK1480953T4 publication Critical patent/DK1480953T4/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
DK03780889.6T 2003-01-09 2003-12-18 Fremgangsmåde til fremstilling af aripiprazol DK1480953T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003002996 2003-01-09
PCT/JP2003/016256 WO2004063162A1 (en) 2003-01-09 2003-12-18 Process for preparing aripiprazole

Publications (2)

Publication Number Publication Date
DK1480953T3 true DK1480953T3 (da) 2005-12-19
DK1480953T4 DK1480953T4 (da) 2010-11-15

Family

ID=32652780

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03780889.6T DK1480953T4 (da) 2003-01-09 2003-12-18 Fremgangsmåde til fremstilling af aripiprazol

Country Status (20)

Country Link
US (1) US6995264B2 (da)
EP (1) EP1480953B2 (da)
JP (2) JP5797090B2 (da)
KR (1) KR100583667B1 (da)
CN (1) CN1263742C (da)
AR (1) AR042702A1 (da)
AT (1) ATE308524T1 (da)
AU (1) AU2003288755C1 (da)
BR (2) BR0305500A (da)
CA (2) CA2458929C (da)
DE (1) DE60302139T3 (da)
DK (1) DK1480953T4 (da)
EG (1) EG23557A (da)
ES (1) ES2250919T5 (da)
HK (1) HK1073110A1 (da)
MX (1) MXPA04002519A (da)
MY (1) MY129831A (da)
SI (1) SI1480953T2 (da)
TW (1) TWI258470B (da)
WO (1) WO2004063162A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058835A2 (en) * 2003-12-16 2005-06-30 Teva Pharmaceutical Industries Ltd. Methods of preparing aripiprazole crystalline forms
US7714129B2 (en) * 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
MXPA06008828A (es) * 2004-02-05 2007-04-25 Teva Pharma Proceso para preparar aripiprazol.
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
KR101041551B1 (ko) * 2004-10-08 2011-06-15 수벤 라이프 사이언시스 리미티드 아리피프라졸 제조를 위해 유용한 신규 중간체와 신규중간체 및 아리피프라졸 제조 방법
US20060079689A1 (en) * 2004-10-12 2006-04-13 Vladimir Naddaka Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
EP1812397A1 (en) * 2004-11-18 2007-08-01 Synthon B.V. Process of making crystalline aripiprazole
CN1303068C (zh) * 2005-01-11 2007-03-07 中国人民解放军第二军医大学 一种阿立哌唑的制备方法
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
JP2009508859A (ja) * 2005-09-15 2009-03-05 エラン ファーマ インターナショナル リミテッド ナノ粒子アリピプラゾール製剤
EP1919453A2 (en) * 2005-12-22 2008-05-14 Teva Pharmaceutical Industries Ltd Processes for reducing particle size of aripiprazole
US20070149782A1 (en) * 2005-12-23 2007-06-28 Michael Brand Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole
US20070238876A1 (en) * 2006-04-10 2007-10-11 Neera Tewari Process for the preparation of aripiprazole
RU2497819C2 (ru) 2007-05-21 2013-11-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина
EP2299814A4 (en) 2008-05-27 2011-06-15 Reviva Pharmaceuticals Inc COMPOSITIONS, SYNTHESIS AND METHOD FOR USE OF ANTIPSYCHOTICS ON PIPERAZINE BASIS
CN101781246B (zh) * 2009-01-15 2012-02-29 成都康弘药业集团股份有限公司 一种合成阿立哌唑的改进方法
KR101705727B1 (ko) 2009-02-26 2017-02-10 레비바 파마슈티칼스, 아이엔씨. 아릴피페라진 유도체의 조성물, 합성, 및 사용 방법
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
WO2016181406A1 (en) * 2015-05-08 2016-11-17 Davuluri Ramamohan Rao Improved process for the preparation of aripiprazole with reduced particle size

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE3034237A1 (de) 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
JP4060523B2 (ja) 1999-11-24 2008-03-12 大塚製薬株式会社 カルボスチリル誘導体の製造法
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
ES2250919T5 (es) 2010-12-03
SI1480953T2 (sl) 2010-12-31
AR042702A1 (es) 2005-06-29
AU2003288755C1 (en) 2015-02-19
DK1480953T4 (da) 2010-11-15
CA2458929A1 (en) 2004-07-09
DE60302139T2 (de) 2006-07-20
BRPI0305500B1 (pt) 2018-01-23
BR0305500A (pt) 2004-11-03
MXPA04002519A (es) 2005-04-04
EP1480953B2 (en) 2010-08-18
JP5797090B2 (ja) 2015-10-21
DE60302139D1 (de) 2005-12-08
AU2003288755B2 (en) 2005-08-25
CA2458929C (en) 2009-09-08
DE60302139T3 (de) 2011-02-24
ATE308524T1 (de) 2005-11-15
ES2250919T3 (es) 2006-04-16
US6995264B2 (en) 2006-02-07
KR100583667B1 (ko) 2006-05-26
JP2014148511A (ja) 2014-08-21
EG23557A (en) 2006-06-05
HK1073110A1 (en) 2005-09-23
CN1590377A (zh) 2005-03-09
EP1480953B1 (en) 2005-11-02
WO2004063162A1 (en) 2004-07-29
CA2676216A1 (en) 2004-07-09
JP2012031203A (ja) 2012-02-16
CN1263742C (zh) 2006-07-12
EP1480953A1 (en) 2004-12-01
TWI258470B (en) 2006-07-21
AU2003288755A1 (en) 2004-08-10
KR20040093655A (ko) 2004-11-06
US20040192915A1 (en) 2004-09-30
TW200418840A (en) 2004-10-01
MY129831A (en) 2007-05-31
SI1480953T1 (sl) 2006-04-30

Similar Documents

Publication Publication Date Title
NO2014027I2 (no) aripiprazol
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1480953T3 (da) Fremgangsmåde til fremstilling af aripiprazol
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
CR8226A (es) Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos
DK1720571T3 (da) Fremgangsmåde til behandling af hæmolytisk sygdom
DK1676786T3 (da) Fremgangsmåde til fremstilling af drikkevarer
CL2008000069A1 (es) Metodo de preparacion de compuestos derivados de 3,4-dihidroquinolina.
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK2093217T3 (da) Fremgangsmåde til fremstilling af form X af aripiprazol
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
FI20055534A (fi) Menetelmä verkkosuolen valmistamiseksi
DK1805316T3 (da) Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy-
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1613599T3 (da) Fremgangsmåde til fremstilling af 5-(halogenacetyl)-8-(substitueret oxy)-(1H)-quinolin-2-oner
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1931618T3 (da) Fremgangsmåde til fremstilling af aniliner
DK1727792T3 (da) Fremgangsmåde til fremstilling af semicarbazoner
DK1717311T3 (da) Fremgangsmåde til fremstilling af lactoperoxidase